CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 13 Issue 4

Digital Transformation: The Modern Pharmaceutical Control Tower

The next generation of analytical tools provides transparency and visibility into the complex nature of the modern pharma supply chain and services that facilitate p...
Continue Reading →
Volume 13 Issue 4

Behavioural Science: An Untapped Opportunity for Medical Affairs

Just proving that an intervention has benefits is not always enough for it to be adopted into clinical practice. Yet in the past, pharma Medical Affairs teams have l...
Continue Reading →
News

Pharma confidence surges as CPhI Worldwide 2021 opens

CPhI Pharma Index reaches record high as pharma confidence in growth rises in all markets CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 Nove...
Continue Reading →
News

OPTIMA pharma and OPTIMA life science combine their expertise in Madrid

Visitors to the exhibition stand of Optima Pharma and Optima Life Science at P-MEC will have the opportunity to find out how the time between an order being placed a...
Continue Reading →
News

Trump coaxes big promises from big pharma

Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse Amid significant press...
Continue Reading →
News

Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced it has ente...
Continue Reading →
News

The cure for Pharma to stop gender diversity stalling is to appoint more women in P&L roles says The Pipeline report

Women Count 2018 found that in the last three years there has been no progress on gender diversity in senior roles in the FTSE 350 – and by some measures, it is goin...
Continue Reading →
News

Salim Haffar to Join PCI Pharma Services as Chief Executive Officer

Bill Mitchell to Assume Role of Executive Co-Chairman Leadership Transition Builds on Strong Growth and Customer-Focused Performance Salim Haffar PCI Pharm...
Continue Reading →
News

Adents Launches Verification Router Service for Pharma Manufacturers & Distributors Powered by New Blockchain Technology Platform

 VRS Solution employs Adents NovaTrack’s Blockchain benefits to address pending DSCSA requirements for sale of returned products. Adents, a leading provider of...
Continue Reading →
News

CPhI Worldwide opens entries for 15th Annual Pharma Awards

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives CPhI Worldwide – organised by UBM (part of Informa PLC) – anno...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026